Core Viewpoint - The 11th Bio-based Conference and Exhibition (Bio-based 2026) will be held from May 20-22, 2026, in Shanghai, China, focusing on promoting green and low-carbon transformation in the industry through various forums and activities [1][15]. Group 1: Event Overview - Bio-based 2026 will feature 10 major upstream and downstream thematic forums, 9 concurrent activities, over 1000 new product displays, and an innovation award ceremony [1][9][15]. - The event aims to facilitate discussions on industry trends, technological innovations, and sustainable practices among industry leaders and brands [1][10]. Group 2: Key Forums and Topics - The event will include forums on critical chemical products and materials, international cooperation, and bio-based materials for packaging, footwear, and automotive applications [10][11][15]. - Specific topics will cover sustainable packaging innovations, carbon reduction practices in various consumer sectors, and the development of biodegradable materials [4][8][11]. Group 3: Participants and Collaborators - Notable participants include global brands and packaging solution companies such as McDonald's, L'Oréal, and Mengniu, as well as bio-based and biodegradable material companies like NatureWorks and 金发科技 [5][6]. - The forums will invite industry leaders from various sectors to discuss collaboration and innovation in sustainable packaging [1][5]. Group 4: Concurrent Activities - Concurrent activities will include a high-level strategic seminar, product and technology release events, and a standard review meeting for bio-based materials [12][15]. - The 4th DT New Leaf Award will also take place, recognizing innovations in materials and applications [15].

Core Viewpoint - The 11th Bio-based Industry Conference & Exhibition (Bio-based 2026) will take place from May 20-22, 2026, in Shanghai, China, focusing on the latest advancements in the bio-based sector and fostering connections between supply and demand sides of the industry [2][20]. Group 1: Event Overview - The event will feature 11 thematic forums, 7 concurrent activities, 1000 new product displays, and an innovation award ceremony, creating a platform for showcasing bio-based technology innovations and applications [3][11]. - Over 50 sponsors have already confirmed their participation, including leading companies in the bio-based materials and chemicals sector [2][3]. Group 2: Focus Areas - The exhibition will emphasize bio-based innovative materials and products in packaging, footwear, 3D printing, and structural components, as well as bio-based monomers and non-food biomass raw materials [5][8]. - The event aims to connect upstream and downstream industries and international resources, promoting new opportunities for industry collaboration [5]. Group 3: Thematic Forums and Activities - The 11 thematic forums will cover key topics such as critical chemicals and materials, international cooperation, and applications in various sectors including packaging, textiles, automotive, and 3D printing [20][22]. - Seven concurrent activities will include brand demand matching sessions, standard review meetings, and new product technology release events [21][22]. Group 4: Innovation and Awards - The 4th DT New Leaf Award will be held concurrently, recognizing innovations in materials, applications, and industry solutions [21][22]. - The event aims to explore the cost-effectiveness and feasibility of bio-based products, enhancing product innovation through strategic discussions with leading brands [8].

Core Viewpoint - The New Leaf Award is a prestigious global award focused on innovation in the bio-based industry, aimed at recognizing and showcasing outstanding products and companies in this sector [2][17]. Group 1: Award Overview - The New Leaf Award, organized by DT New Materials, is recognized as the "Oscar of the bio-based industry" and has awarded over 100 innovative bio-based products through a professional evaluation team [2][17]. - The award features four categories: Innovation Material Award, Innovation Application Award, Innovation Industry Solution Award, and Most Commercially Valuable Award [6][2]. Group 2: Application Timeline and Process - The application for the 2026 New Leaf Award has started, with key dates including: - Application period: December 1, 2025, to March 13, 2026 [11]. - Online voting (pre-selection): March 16 to March 22, 2026 [11]. - Online competition and expert review (final selection): March 23 to March 27, 2026 [11]. - Award ceremony: May 21, 2026, during the Bio-based 2026 Conference [3][11]. Group 3: Evaluation Criteria - The evaluation criteria for the awards include: - Innovation in technology and application, functionality, commercial value, and sustainability, with varying weightings for each award category [9]. - For the Innovation Material Award, the criteria weightings are: 30% technical innovation, 10% application innovation, 25% functionality, 20% commercial value, and 15% sustainability [9]. Group 4: Benefits of Participation - Participating companies can benefit from free publicity, leveraging DT New Materials' extensive network of over 100,000 industry followers and 100+ communication groups [10]. - Award-winning companies will receive a high-end trophy and certificate at the award ceremony, providing significant visibility and recognition in the industry [13].

Core Viewpoint - The New Leaf Award is a prestigious global award focused on innovation in the bio-based industry, aimed at recognizing and showcasing outstanding products and companies in this sector, often referred to as the "Oscar of the bio-based industry" [2][17]. Group 1: Award Structure - The New Leaf Award features four main categories: Innovation Material Award, Innovation Application Award, Innovation Industry Solution Award, and Most Commercially Valuable Award [6][2]. - Over 100 innovative bio-based products have been recognized through this award, highlighting its significance in the industry [2]. Group 2: Application Timeline and Process - The application process for the 2026 New Leaf Award has commenced, with key dates including: - Application period: December 1, 2025, to March 13, 2026 [11]. - Online voting (pre-selection): March 16 to March 22, 2026 [11]. - Online competition and expert review (final selection): March 23 to March 27, 2026 [11]. - Award ceremony: May 21, 2026, during the Bio-based 2026 conference [3][11]. Group 3: Evaluation Criteria - The evaluation criteria for the awards include: - Innovation in technology and application, functionality, commercial value, and sustainability, with varying weightings for each category [9]. - For the Innovation Material Award, the criteria weightings are: 30% technical innovation, 10% application innovation, 25% functionality, 20% commercial value, and 15% sustainability [9]. Group 4: Benefits of Participation - Participating companies can benefit from free publicity, leveraging a platform with over 100,000 industry followers and 100+ communication groups [10]. - Award-winning companies will receive a high-end trophy and certificate, along with the opportunity to celebrate their achievements at a grand award ceremony attended by industry leaders [13].

Core Viewpoint - The New Leaf Award, organized by DT New Materials, is a prestigious global award focused on innovation in the bio-based industry, aimed at recognizing and showcasing outstanding products and companies in this sector [2][17]. Group 1: Award Structure - The New Leaf Award features four main categories: Innovation Material Award, Innovation Application Award, Innovation Industry Solution Award, and Most Commercially Valuable Award [6][2]. - Over 100 innovative bio-based products have been awarded in previous editions, establishing the New Leaf Award as the "Oscar of the bio-based industry" [2]. Group 2: Application Timeline and Process - The application process for the 2026 New Leaf Award has commenced, with key dates including: - Application and nomination: December 1, 2025 - March 13, 2026 - Online voting (pre-selection): March 16 - March 22, 2026 - Online competition and expert review (final selection): March 23 - March 27, 2026 - Award ceremony: May 21, 2026, during the Bio-based 2026 Conference [8][11]. - The evaluation process includes two rounds of professional screening and assessments by over 50 core experts from the industry [12]. Group 3: Evaluation Criteria - The evaluation criteria for the awards are categorized as follows: - Innovation Material Award: 30% Technical Innovation, 10% Application Innovation, 25% Functionality, 20% Commercial Value, 15% Sustainability - Innovation Application Award: 10% Technical Innovation, 30% Application Innovation, 25% Functionality, 20% Commercial Value, 15% Sustainability - Most Commercially Valuable Award: 15% Technical Innovation, 20% Application Innovation, 20% Functionality, 30% Commercial Value, 15% Sustainability - Innovation Industry Solution Award: 20% Technical Innovation, 20% Application Innovation, 30% Functionality, 15% Commercial Value, 15% Sustainability [9]. Group 4: Benefits of Participation - Participating companies can benefit from free publicity, leveraging DT New Materials' extensive network of over 100,000 industry followers and 100+ communication groups [10]. - Award-winning companies will receive a high-end trophy and certificate during the award ceremony, providing significant exposure and recognition in front of industry leaders and representatives [13].

Core Viewpoint - The European Commission is set to release a new bioeconomy strategy on November 27, 2025, aimed at reducing reliance on fossil fuels and enhancing the value and processing levels of bio-based products [1] Group 1: Strategic Goals - The core objective of the strategy is to accelerate the development and application of bio-based products [1] - The strategy focuses on scaling up innovative investments, creating new markets, ensuring sustainable biomass supply, and promoting global cooperation [1] Group 2: Implications for Finland - Finland welcomes the strategy, viewing it as an opportunity for agricultural economic diversification [1] - The strategy is expected to enhance the EU's competitiveness and sustainability by simplifying regulations, accelerating authorizations, and providing technical support [1] - It also supports climate goals and strategic autonomy [1]

Core Insights - The 20th Central Committee's Fourth Plenary Session emphasizes the strategic importance of biomanufacturing as a key driver for economic transformation and high-quality development in China [1] Group 1: Strategic Importance of Biomanufacturing - Biomanufacturing is positioned as a critical sector for future economic growth, with a focus on core technology breakthroughs and the cultivation of an industrial ecosystem [1] - The approach to biomanufacturing should leverage China's unique conditions and institutional advantages, aiming for a comprehensive view of the entire industrial chain [1] Group 2: Characteristics of China's Biomanufacturing Industry - China's biomanufacturing industry showcases significant features such as integrated innovation, sustainability, and empowerment through the intersection of biotechnology and various fields [2] - The industry benefits from a complete industrial system and supply chain, allowing for effective engineering and market application of biomanufacturing technologies [2] Group 3: Challenges and Gaps - There are notable gaps in core technologies, original capabilities, and competitiveness in high-value products compared to international standards, particularly in high-end industrial enzymes and key equipment manufacturing [3] - A more systematic and forceful approach is needed to drive high-quality development in the biomanufacturing sector [3] Group 4: Recommendations for Development - Strengthening top-level design and strategic guidance is essential, including clearer long-term planning and prioritization of technology directions [3] - Establishing a collaborative innovation ecosystem that integrates industry, academia, and research institutions is crucial for overcoming challenges in transitioning from laboratory samples to industrial products [3] Group 5: Investment and Infrastructure - Diversifying investment and market mechanisms is necessary, including government funding and attracting social capital into biomanufacturing [4] - Building a robust foundation in talent and infrastructure is vital, with an emphasis on interdisciplinary talent cultivation and the establishment of major technological infrastructures [4]

Core Insights - The signing of five projects in the semiconductor sector at the Qidong Economic Development Zone marks a significant step in enhancing the region's industrial capabilities and supporting Shanghai's large semiconductor enterprises [1][3] Group 1: Industrial Development - The Qidong Economic Development Zone is positioned as a key area for the Yangtze River Delta's industrial innovation and green development, with a focus on semiconductor and biopharmaceutical industries [2][4] - The zone aims to integrate closely with Shanghai's industrial and innovation chains, leveraging its proximity to the city to attract high-quality projects [1][2] Group 2: Strategic Initiatives - Qidong has established the Qidong Life and Health Technology Park, which has already attracted over 60 pharmaceutical companies, with a high occupancy rate in its initial phases [3][4] - The park is designed to facilitate rapid commercialization of innovative drugs, providing tailored facilities for companies to quickly set up operations [3][4] Group 3: Investment and Growth Targets - The Qidong Economic Development Zone aims to achieve a high-tech industry scale of 30 billion yuan and over 130 high-tech enterprises by 2027 [5] - In the first half of the year, high-tech industry investment in the park accounted for 63.8% of total investments, significantly higher than the city average [4]

Core Viewpoint - Anhui Huaheng Biotechnology Co., Ltd. (Huaheng Bio) has submitted an application for listing on the Hong Kong Stock Exchange, with Huatai International as the sole sponsor [1]. Company Overview - Huaheng Bio is a pioneer in synthetic biology, focusing on the research, large-scale production, and commercialization of bio-based products through biomanufacturing technology. The company has established a leading position in the industry over the past 20 years [3]. - The company is recognized as one of the most comprehensive enterprises in the commercialization of bio-based products through synthetic biology, being the first globally to industrialize the anaerobic fermentation of a series of amino acids, including L-Alanine and L-Valine. By 2024, it is projected to hold the largest market share for L-Alanine and L-Valine globally [3]. Product Portfolio - As of June 30, 2025, Huaheng Bio has established stable long-term partnerships with over 768 customers across 85 countries in Asia, Europe, and the Americas. Its main bio-based products include amino acids (primarily alanine series, L-Valine, tryptophan, arginine), vitamins (D-Calcium Pantothenate, D-Pantothenol, inositol), and other bio-based products (1,3-propanediol, succinic acid, malic acid, arbutin) [4]. - The company employs two green manufacturing technology platforms: fermentation and enzyme catalysis, focusing on microbial cell factories and enzyme-based production processes to reduce pollution, lower energy consumption, and minimize carbon footprints [4]. Market Potential - The global bio-based products market is expected to grow from $22.8 billion in 2020 to $42.1 billion by 2024, with a compound annual growth rate (CAGR) of 16.6%. It is projected to further increase to $80.1 billion by 2030 and $109.1 billion by 2035, with CAGRs of 11.3% and 6.4% respectively [5]. - Companies with green manufacturing capabilities, large-scale production technologies, and collaborative advantages in the supply chain are anticipated to experience unprecedented growth opportunities in this market [5]. Financial Performance - The company reported revenues of approximately RMB 1.419 billion, RMB 1.938 billion, RMB 2.178 billion, and RMB 1.489 billion for the years 2022, 2023, 2024, and the first half of 2025, respectively. The corresponding profits for these periods were approximately RMB 319 million, RMB 447 million, RMB 185 million, and RMB 109 million [5][7].

Core Insights - The company, Huaheng Biological, announced an investment of 320 million yuan to establish an "Artificial Intelligence Precision Fermentation and Protein Engineering Shared Demonstration Project" in Changfeng County, Hefei [1] - This investment aims to enhance production efficiency and product quality through advanced microbial fermentation technology and AI-driven process control [1] - The project is expected to take 36 months to complete and will be funded primarily through the company's own or self-raised funds [1] Investment Details - The total investment agreements signed by the company with the Changfeng (Shuangfeng) Economic Development Zone Management Committee in the past 12 months amount to 710 million yuan, including a previous agreement of 390 million yuan for a "AI-driven Biological Manufacturing R&D and Pilot Demonstration Base" [2] - The new project will be located at the intersection of Shuangfeng Road and Yingzhou Road in the Shuangfeng Economic Development Zone [1] Technological Advancements - The investment will leverage cutting-edge technologies in synthetic biology and metabolic engineering, transitioning biological manufacturing from traditional fermentation to precision and intelligence [1] - The company aims to establish an intelligent production system to meet market demands for high-quality, low-cost products, thereby enhancing its core competitiveness and maintaining its industry leadership [1]